Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery · Elkhorn, NE
NPI
1528220209
Since 2008
Specialty
Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery
Code 207VF0040X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
717 N 190th Plz, Ste. # 1100
Elkhorn, NE, 68022
Phone (402) 815-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
12,546 services
Medicare patients, 2024
444
Average age 75
Drug cost, 2024
$278K
1,359 prescriptions
Company payments, 2025
$890
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica N Bracken was code J0585 (injection, onabotulinumtoxina, 1 unit), 8,000 times for 39 patients. In total Jessica N Bracken billed 12,546 services in 65 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 8,000 | 39 | $4.98 | $40K |
| 99214 Office E&M - Established | Office | 342 | 258 | $84.61 | $29K |
| 81003 Clinical Chemistry | Office | 307 | 207 | $2.18 | $669 |
| 51701 Other Organ Systems | Office | 230 | 214 | $28.24 | $6,496 |
| 81001 Clinical Chemistry | Office | 207 | 120 | $3.09 | $640 |
| 99204 Office E&M - New | Office | 114 | 114 | $109.88 | $13K |
| 51741 Test - Miscellaneous | Office | 69 | 69 | $5.02 | $347 |
| 52287 Cystourethroscopy | Office | 68 | 39 | $266.34 | $18K |
| 51797 Other Organ Systems | Office | 68 | 68 | $134.70 | $9,159 |
| 51729 Other Organ Systems | Office | 68 | 68 | $248.56 | $17K |
| 51784 Neurologic | Office | 67 | 67 | $23.39 | $1,567 |
| 99213 Office E&M - Established | Office | 65 | 60 | $62.33 | $4,051 |
| 51798 Ultrasound - Nonspecific | Office | 65 | 49 | $7.59 | $494 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 31 | $12.12 | $376 |
| Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens | Office | 19 | 18 | $17.40 | $331 |
By year: 2022 $156K for 5,385 services; 2023 $186K for 8,659 services; 2024 $199K for 12,546 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 307 | 207 | $2.18 | $669 |
| 81001 Clinical Chemistry | 207 | 120 | $3.09 | $640 |
| Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens | 19 | 18 | $17.40 | $331 |
Medicare prescription drug claims, 2024
In 2024, the drug Jessica N Bracken prescribed most often to Medicare patients was Methenamine Hippurate, with 208 prescriptions and refills. In total Jessica N Bracken wrote 1,359 Medicare prescriptions that cost $278K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methenamine Hippurate Generic | 208 | 301 | 61 | $12K |
| Myrbetriq Mirabegron | 180 | 249 | 55 | $109K |
| Gemtesa Vibegron | 161 | 245 | 50 | $118K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 121 | 121 | 80 | $439 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 114 | 120 | 73 | $1,667 |
| Estradiol Generic | 110 | 314 | 73 | $8,476 |
| Solifenacin Succinate Generic | 86 | 147 | 34 | $2,815 |
| Ciprofloxacin Hcl Generic | 84 | 84 | 54 | $345 |
| Cephalexin Generic | 53 | 53 | 38 | $207 |
| Clobetasol Propionate Generic | 27 | 32 | 19 | $804 |
| Fluconazole Generic | 27 | 29 | 19 | $121 |
| Ibuprofen Generic | 18 | 18 | 18 | $33.44 |
| Oxycodone Hcl Generic | 16 | 16 | 15 | $27.11 |
| Mirabegron Er Mirabegron | 14 | 18 | Under 11 | $5,244 |
| Glydo Lidocaine Hcl | 13 | 13 | Under 11 | $706 |
Brand drugs: - claims; generic drugs: 950 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica N Bracken $890 ($890 in general payments such as food, travel and fees) from 10 companies. The largest payer was Astellas Pharma US Inc with $263.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 8 | $263 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $229 |
| Boston Scientific Corporation BSX | 1 | $153 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $101 |
| Coloplast Corp | 2 | $34.89 |
| 180 Medical, Inc. | 1 | $27.95 |
| Abbvie Inc. ABBV | 2 | $27.27 |
| Exeltis, USA Inc. | 1 | $19.25 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.74 |
| Laborie Medical Technologies Corp. | 1 | $16.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.